Vikram Verghese Sells 16,766 Shares of Heartflow (NASDAQ:HTFL) Stock

Heartflow, Inc. (NASDAQ:HTFL) CFO Vikram Verghese sold 16,766 shares of Heartflow stock in a transaction on Friday, September 18th. The stock was sold at an average price of $50.75, for a total value of $850,874.50. Following the sale, the chief financial officer directly owned 155,183 shares of the company’s stock, valued at approximately $7,875,537.25. This trade represents a 9.75% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan.

Vikram Verghese also recently made the following trade(s):

• On Thursday, September 17th, Vikram Verghese sold 7,579 shares of Heartflow stock. The shares were sold at an average price of $50.11, for a total value of $379,783.69.
• On Tuesday, September 15th, Vikram Verghese sold 668 shares of Heartflow stock. The stock was sold at an average price of $50.01, for a total value of $33,406.68.
• On Monday, September 14th, Vikram Verghese sold 4,593 shares of Heartflow stock. The shares were sold at an average price of $50.24, for a total value of $230,752.32.
• On Friday, September 11th, Vikram Verghese sold 29,714 shares of Heartflow stock. The shares were sold at an average price of $50.06, for a total transaction of $1,487,482.84.
• On Tuesday, September 8th, Vikram Verghese sold 6,640 shares of Heartflow stock. The stock was sold at an average price of $50.03, for a total transaction of $332,199.20.
• On Thursday, September 3rd, Vikram Verghese sold 27,540 shares of Heartflow stock. The shares were sold at an average price of $49.69, for a total transaction of $1,368,462.60.
• On Wednesday, September 2nd, Vikram Verghese sold 5,876 shares of Heartflow stock. The stock was sold at an average price of $50.60, for a total transaction of $297,325.60.

Heartflow Trading Up 2.4%

Shares of NASDAQ HTFL traded up $1.18 during midday trading on Friday, reaching $50.75. 6,606,910 shares of the stock were exchanged, compared to its average volume of 1,824,326. Heartflow, Inc. has a 12 month low of $20.13 and a 12 month high of $52.22. The business has a 50-day simple moving average of $37.75 and a two-hundred day simple moving average of $31.70.

Heartflow (NASDAQ:HTFL) last released its quarterly earnings data on Thursday, August 13th. The company reported ($0.07) EPS for the quarter, beating analysts’ consensus estimates of ($0.22) by $0.15. The business had revenue of $64.08 million during the quarter. Heartflow had a negative net margin of 55.82% and a negative return on equity of 23.52%. The business’s quarterly revenue was up 47.7% on a year-over-year basis. Equities research analysts predict that Heartflow, Inc. will post -0.75 EPS for the current year.

Institutional Inflows and Outflows

A number of hedge funds have recently added to or reduced their stakes in HTFL. Engineers Gate Manager LP acquired a new stake in Heartflow in the 2nd quarter valued at $590,000. Integrated Wealth Concepts LLC bought a new position in shares of Heartflow in the 2nd quarter valued at about $53,000. Squarepoint Ops LLC grew its holdings in shares of Heartflow by 72.0% in the 2nd quarter. Squarepoint Ops LLC now owns 87,052 shares of the company’s stock valued at $2,554,000 after acquiring an additional 36,441 shares in the last quarter. Arizona State Retirement System acquired a new stake in shares of Heartflow in the second quarter valued at about $312,000. Finally, Allianz Asset Management GmbH bought a new stake in Heartflow during the second quarter worth about $1,557,000.

Wall Street Analyst Weigh In

HTFL has been the topic of several recent analyst reports. Canaccord Genuity Group lifted their price objective on Heartflow from $37.00 to $45.00 and gave the company a “buy” rating in a report on Friday, August 14th. UBS Group initiated coverage on shares of Heartflow in a report on Wednesday, September 9th. They set a “neutral” rating and a $55.00 target price on the stock. JPMorgan Chase & Co. upped their price target on shares of Heartflow from $35.00 to $45.00 and gave the company an “overweight” rating in a report on Friday, August 14th. Wells Fargo & Company increased their price objective on shares of Heartflow from $37.00 to $39.00 and gave the stock an “overweight” rating in a research report on Friday, August 14th. Finally, Morgan Stanley lifted their target price on Heartflow from $35.00 to $40.00 and gave the company an “equal weight” rating in a research report on Friday, August 14th. One investment analyst has rated the stock with a Strong Buy rating, eight have issued a Buy rating, two have issued a Hold rating and one has assigned a Sell rating to the company. According to MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and an average price target of $44.88.

About Heartflow

Heartflow, Inc is a medical technology company that develops artificial intelligence and imaging solutions for the diagnosis and management of coronary artery disease. Its platform analyzes data from coronary computed tomography angiography (CCTA) scans to create personalized, three-dimensional models of a patient’s coronary arteries.

The company’s primary offering, Heartflow Analysis, is designed to provide noninvasive estimates of fractional flow reserve derived from computed tomography (FFR^CT).